Optimal LAI Treatment in Schizophrenia - ROVI

This webinar will explore the use of long-acting injections (LAIs) in psychiatry, focusing on their misuse and underuse. Key considerations such as tolerability, patient choice, and consistency in prescribing decisions will be discussed. The session will conclude with a moderated Q&A, providing attendees the opportunity to engage with an expert in the field.

By the end of this webinar, participants will be able to:

• Recognise the shortcomings of oral antipsychotics.
• Acknowledge the impact of relapse.
• Understand the moral imperative for consistency in prescribing decisions.
• Recognise the dangers of first-generation LAIs.
• Understand the challenges of optimal dosing for first-generation LAIs.
• Understand the benefits of second-generation LAIs.
• Understand the differences between second-generation LAIs.

This session is designed for healthcare professionals interested in deepening their understanding of antipsychotic treatments, with a focus on Risperidone's role in optimising patient care in schizophrenia.

Please note: This webinar is commissioned by ROVI and is exclusively available to staff working within ROVI.